Patent Invalidity Heading To Supreme Court In April As Rx Firms Square Off In Microsoft Case
Executive Summary
Brand and generic drug manufacturers have squared off on opposite sides of a case to be taken up by the Supreme Court in April that could change the standard of proof required to show that a patent is invalid.